YZYBIO-B Reports Narrowed Interim Loss of RMB 6.26 Million, Down 89.36% Year-on-Year
Stock News
Aug 28
YZYBIO-B (02496) has announced its interim results for the six months ended June 30, 2026, revealing a significant reduction in its net loss. The company recorded a net loss of RMB 6.26 million for the reporting period, which reflects a sharp narrowing of 89.36% compared to the same period last year.
During the period, the group's revenue reached RMB 33.143 million, marking a decrease of 10.87% year-on-year. Meanwhile, research and development expenses were reported at RMB 17.581 million, down substantially by 70.79% from the prior corresponding period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.